Salvage chemotherapy for epithelial ovarian carcinoma.

Salvage chemotherapy for epithelial ovarian carcinoma.

Item
http://www.wikidata.org/entity/Q40579673
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen.TP53 status determines clinical significance of ERBB2 expression in ovarian cancer.p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.The significance of c.690G>T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome.Nuclear survivin expression is a positive prognostic factor in taxane-platinum-treated ovarian cancer patients.High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer.High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results.Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.
P2860

Salvage chemotherapy for epithelial ovarian carcinoma.

Item
http://www.wikidata.org/entity/Q40579673
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Salvage chemotherapy for epithelial ovarian carcinoma.
@en
type
label
Salvage chemotherapy for epithelial ovarian carcinoma.
@en
prefLabel
Salvage chemotherapy for epithelial ovarian carcinoma.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Salvage chemotherapy for epithelial ovarian carcinoma.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921